Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
Daniel E. Weiner(Tufts Medical Center), Manjula Kurella Tamura(University of California, San Francisco), Alexander P. Auchus(Jackson Memorial Hospital), John Nord(Lake City VA Medical Center), Laura H. Coker(Wake Forest University), Clinton B. Wright(National Institute of Neurological Disorders and Stroke), Jeff D. Williamson(University Memory and Aging Center), Alan J. Lerner(University Hospitals of Cleveland), Mohammad G. Saklayen(Wright State University), Anthony A. Killeen(University of Minnesota), Gordon J. Chelune(University of Utah), Yelena Slinin, William E. Haley(Jacksonville College), Paul L. Kimmel(Anna Needs Neuroblastoma Answers), Suzanne Oparil(University of Alabama at Birmingham), Michel Chonchol(University of Colorado Anschutz Medical Campus), Sarah A. Gaussoin(Wake Forest University)
Cited by 79
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k